- ¥4tn
- ¥4tn
- ¥922bn
- 94
- 19
- 94
- 81
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 27.18 | ||
| PEG Ratio (f) | 1.94 | ||
| EPS Growth (f) | 16.33% | ||
| Dividend Yield (f) | 1.19% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.9 | ||
| Price to Tang. Book | 5.03 | ||
| Price to Free Cashflow | 33.62 | ||
| Price to Sales | 4.03 | ||
| EV to EBITDA | 16.03 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 10.41% | ||
| Return on Equity | 9.55% | ||
| Operating Margin | 16.62% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 628,897 | 613,842 | 703,303 | 820,209 | 921,863 | 1,027,761 | 1,092,419 | 8.99% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +13.61 | -8.47 | +16.79 | +2.86 | +20.12 | +19.69 | +15.15 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Directors
- Takayoshi Mimura CHM (67)
- Shinjiro Sato PRE (61)
- Naoki Muto CFO (58)
- Kyo Nishikawa CHO (62)
- Fumihisa Hirose CTO
- Katsuya Takeuchi CIO
- Toshiaki Takagi SME (63)
- Shoji Hatano MEO (62)
- Toshihiko Osada MEO
- Hikaru Samejima MEO (57)
- Kazunori Hirose SEO
- Tetsuya Kumei SEO
- Itaru Sakaguchi SEO
- Tsuyoshi Tomita SEO
- Nishizaki Hitoshi DSL
- Kenichi Ikeda DSL
- Keiji Takeda DHR
- Probir Das EXO
- Robato Deraiku EXO
- Robert DeRyke EXO
- Antoinette Gawin EXO
- Kazunobu Handa EXO
- Yagi Hiroshi EXO
- Paul Holbrook EXO
- Masanori Hoshino EXO
- Norimasa Kunimoto EXO (58)
- Takeshi Kuroo EXO
- Tomoko Manabe EXO
- Masayuki Maruta EXO
- Miho Mizuguchi EXO
- Hiroshi Nagumo EXO
- Toshio Nakashima EXO
- James Rushworth EXO
- Kazuhisa Senshu EXO
- Takanori Shibazaki DRC (59)
- Yukiko Kuroda IND (57)
- Masaichi Nakamura IND (64)
- Hidenori Nishi IND (70)
- Soichiro Uno IND (58)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 17th, 1921
- Public Since
- June 21st, 1982
- No. of Shareholders
- 45,195
- No. of Employees
- 30,591
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Tokyo Stock Exchange- Shares in Issue
- 1,474,059,005
- Address
- 2-44-1, Hatagaya, SHIBUYA-KU, 151-0072
- Web
- https://www.terumo.co.jp/
- Phone
- +81 333748111
- Auditors
- KPMG AZSA LLC
Upcoming Events for 4543
Terumo Corp Annual Shareholders Meeting
Q1 2026 Terumo Corp Earnings Release
Similar to 4543
Alfresa Holdings
Tokyo Stock Exchange
Asahi Intecc Co
Tokyo Stock Exchange
Aso International
Tokyo Stock Exchange
As One
Tokyo Stock Exchange
Atect
Tokyo Stock Exchange
FAQ
What is the Terumo share price?
As of Today at 23:38 UTC, shares in Terumo are trading at ¥2,763. This share price information is delayed by 15 minutes.
How has the Terumo share price performed this year?
Shares in Terumo last closed at ¥2,763 and the price had moved by +6.37% over the past 365 days. In terms of relative price strength the Terumo share price has outperformed the Nikkei 225 Index by +12.1% over the past year.
What are the analyst and broker recommendations for Terumo?
The overall consensus recommendation for Terumo is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Terumo dividend yield?
The Terumo dividend yield is 0.87% based on the trailing twelve month period.
Does Terumo pay a dividend?
Last year, Terumo paid a total dividend of ¥24, and it currently has a trailing dividend yield of 0.87%.Looking ahead, the next dividend pay date is 2025-06-01.
When does Terumo next pay dividends?
We do not have data on when Terumo is to next pay dividends. The historic dividend yield on Terumo shares is currently 0.87%.
How do I buy Terumo shares?
To buy shares in Terumo you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Terumo?
As of the previous close price of ¥2,763, shares in Terumo had a market capitalisation of ¥4tn.
Where are Terumo shares listed?
Here are the trading details for Terumo:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 4543
What kind of share is Terumo?
Based on an overall assessment of its quality, value and momentum Terumo is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Terumo share price forecast for 2025?
The analyst consensus target price for shares in Terumo is ¥3,298. That is 19.35% above the last closing price of ¥2,763.
Analysts covering Terumo currently have a consensus Earnings Per Share (EPS) forecast of ¥87 for the next financial year.
Find out moreWhat is the trend in the Terumo share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Terumo. Over the past six months, its share price has outperformed the Nikkei 225 Index by +2.8%.
As of the last closing price of ¥2,763, shares in Terumo were trading -2.33% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Terumo PE Ratio?
The Terumo PE ratio based on its reported earnings over the past 12 months is 27.18. The shares last closed at ¥2,763.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Terumo?
Terumo's management team is headed by:
- Takayoshi Mimura - CHM
- Shinjiro Sato - PRE
- Naoki Muto - CFO
- Kyo Nishikawa - CHO
- Fumihisa Hirose - CTO
- Katsuya Takeuchi - CIO
- Toshiaki Takagi - SME
- Shoji Hatano - MEO
- Toshihiko Osada - MEO
- Hikaru Samejima - MEO
- Kazunori Hirose - SEO
- Tetsuya Kumei - SEO
- Itaru Sakaguchi - SEO
- Tsuyoshi Tomita - SEO
- Nishizaki Hitoshi - DSL
- Kenichi Ikeda - DSL
- Keiji Takeda - DHR
- Probir Das - EXO
- Robato Deraiku - EXO
- Robert DeRyke - EXO
- Antoinette Gawin - EXO
- Kazunobu Handa - EXO
- Yagi Hiroshi - EXO
- Paul Holbrook - EXO
- Masanori Hoshino - EXO
- Norimasa Kunimoto - EXO
- Takeshi Kuroo - EXO
- Tomoko Manabe - EXO
- Masayuki Maruta - EXO
- Miho Mizuguchi - EXO
- Hiroshi Nagumo - EXO
- Toshio Nakashima - EXO
- James Rushworth - EXO
- Kazuhisa Senshu - EXO
- Takanori Shibazaki - DRC
- Yukiko Kuroda - IND
- Masaichi Nakamura - IND
- Hidenori Nishi - IND
- Soichiro Uno - IND